doi:10.16150/j.1671-2870.2017.06.003

[1] Cunningham RL.Mechanism and clinical aspects of chronic arterial hypertension[J]. Cal State J Med,1912, 10(7):303-305.
[2] The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure[J]. Arch Intern Med,1988,148(5):1023-1038.
[3] Mancia G, De Backer G, Dominiczak A, et al.2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology(ESC)[J]. J Hypertens,2007,25(6):1105-1187.
[4] Mancia G, Fagard R, Narkiewicz K, et al.2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)[J]. J Hypertens,2013,31(7):1281-1357.
[5] James PA, Oparil S, Carter BL, et al.2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)[J]. JAMA,2014,311(5):507-520.
[6] 施仲伟. 我看JNC 8:没了名分成绝唱, 有些底气靠质量[M]//葛均波, 方唯一, 沈卫峰. 现代心脏病学进展2014. 1版. 上海: 复旦大学出版社,2014:45-47.
[7] Qaseem A, Wilt TJ, Rich R, et al.Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians[J]. Ann Intern Med,2017,166(6):430-437.
[8] Wright JT Jr, Fine LJ, Lackland DT, et al.Evidence supporting a systolic blood pressure goal of less than 150 mmHg in patients aged 60 years or older: the minority view[J]. Ann Intern Med,2014,160(7):499-503.
[9] Borden WB, Maddox TM, Tang F, et al.Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry[J]. J Am Coll Cardiol,2014,64(21):2196-2203.
[10] Ambrosius WT, Sink KM, Foy CG, et al.The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial(SPRINT)[J]. Clin Trials,2014,11(5):532-546.
[11] SPRINT Research Group, Wright JT Jr, Williamson JD, et al.A Randomized Trial of Intensive versus Standard Blood-Pressure Control[J]. N Engl J Med,2015,373(22):2103-2116.
[12] Verdecchia P, Angeli F, Reboldi G.The SPRINT trial[J]. J Am Soc Hypertens,2015,9(10):750-753.
[13] National Institutes of Health. Landmark NIH study shows intensive blood pressure management may save lives: lower blood pressure target greatly reduces cardiovascular complications and deaths in older adults[R].2017-10-26[2017-11-02].https://www.nih.gov/news-events/news-releases/landmark-nih-study-shows-intensive-blood-pressure-mana-gement-may-save-lives.
[14] Williamson JD, Supiano MA, Applegate WB, et al.Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial[J]. JAMA,2016,315(24):2673-2682.
[15] Phillips RA.Current and future treatment of hypertension in the SPRINT Era[J]. Methodist Debakey Cardiovasc J,2015,11(4):206-213.
[16] Tsioufis C, Tousoulis D.SPRINT Results Are Life-Saving, Guideline-Changing, and Hypertension Research-Intensifying[J]. Hellenic J Cardiol,2015,56(6):529-530.
[17] Leung AA, Daskalopoulou SS, Dasgupta K, et al.Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults[J]. Can J Cardiol,2017,33(5):557-576.
[18] Gabb GM, Mangoni AA, Anderson CS, et al.Guideline for the diagnosis and management of hypertension in adults-2016[J]. Med J Aust,2016,205(2):85-89.
[19] Fuster V.No Such thing as ideal blood pressure: A case for personalized medicine[J]. J Am Coll Cardiol,2016,67(25):3014-3015.
[20] Filippone EJ, Foy AJ.Blood pressure management in the wake of SPRINT[J]. Cleve Clin J Med,2016,83(3):196-198.
[21] Esler M.SPRINT, or False Start, Toward a lower universal treated blood pressure target in hypertension[J]. Hypertension,2016,67(2):266-267.
[22] Franklin SS, Jacobs MJ, Wong ND, et al.Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey(NHANES) Ⅲ[J]. Hypertension,2001,37(3):869-874.
[23] Thomopoulos C, Parati G, Zanchetti A.Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials[J]. J Hypertens,2014,32(12):2285-2295.
[24] Kjeldsen SE, Narkiewicz K, Hedner T, et al.The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg[J]. Blood Press,2016,25(2):63-66.
[25] Lonn EM, Yusuf S.Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mmHg target? An antagonist view from the HOPE-3 Trial(Heart Outcomes Evaluation-3)[J]. Circulation,2016,134(18):1311-1313.
[26] Myers MG, Godwin M, Dawes M, et al.Measurement of blood pressure in the office: recognizing the problem and proposing the solution[J]. Hypertension,2010,55(2):195-200.
[27] Kjeldsen SE, Lund-Johansen P, Nilsson PM, et al.Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials[J]. Hypertension,2016,67(5):808-812.
[28] Myers MG, Campbell NR.Unfounded concerns about the use of automated office blood pressure measurement in SPRINT[J]. J Am Soc Hypertens,2016,10(12):903-905.
[29] Bundy JD, Li C, Stuchlik P, et al.Systolic blood pressure reduction and risk of cardiovascular disease and mortality: A systematic review and network meta-analysis[J]. JAMA Cardiol,2017,2(7):775-781.
[30] Tsai WC, Wu HY, Peng YS, et al.Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: A systematic review and meta-analysis[J]. JAMA Intern Med,2017,177(6):792-799.
[31] Bakris GL.The Implications of blood pressure measurement methods on treatment targets for blood pressure[J]. Circulation,2016,134(13):904-905.
[32] Bakris G.Response by Bakris to letter regarding article, "The implications of blood pressure measurement metho-ds on treatment targets for blood pressure"[J]. Circulation,2017,135(7):e47.
[33] Cushman WC, Whelton PK, Fine LJ, et al.SPRINT Trial results: Latest news in hypertension management[J]. Hypertension,2016,67(2):263-265.
[34] Cushman WC, Evans GW, Rodriguez CJ, et al.Blood pressure intervention and control in the systolic blood pressure intervention trial (SPRINT)[J]. J Am Soc Hypertens,2016,10(4S):e4.
[35] Myers MG, Valdivieso M, Kiss A.Use of automated office blood pressure measurement to reduce the white coat response[J]. J Hypertens,2009,27(2):280-286.
[36] Agarwal R. Implications of blood pressure measurement technique for implementation of Systolic Blood Pressure Intervention Trial(SPRINT)[J]. J Am Heart Assoc,2017,6(2),pii:e004536.
[37] Filipovsky J, Seidlerová J, Kratochvíl Z, et al.Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients[J]. Blood Press,2016,25(4):228-234.
[38] 施仲伟. 美国胆固醇指南和高血压指南批评声音略显嘈杂[J]. 诊断学理论与实践,2014,13(1):39-43.
[39] Schiffrin EL, Calhoun DA, Flack JM.Do We Need a New Definition of Hypertension After SPRINT?[J]. Am J Hypertens,2016,29(10):1127-1129.
[40] ACCORD Study Group, Cushman WC, Evans GW, et al.Effects of intensive blood-pressure control in type 2 diabetes mellitus[J]. N Engl J Med,2010,362(17):1575-1585.
[41] Lonn EM, Bosch J, López-Jaramillo P, et al.Blood-Pressure lowering in intermediate-risk persons without cardiovascular disease[J]. N Engl J Med,2016,374(21):2009-2020.
[42] Elgendy IY, Bavry AA, Gong Y, et al.Long-term mortality in hypertensive patients with coronary artery disease: Results from the US Cohort of the International Verapamil (SR)/Trandolapril Study[J]. Hypertension,2016,68(5):1110-1114.
[43] Mancia G, Kjeldsen SE, Zappe DH, et al.Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial[J]. Eur Heart J,2016,37(12):955-964.
[44] 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管病杂志,2011,39(7):579-616.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 460-468.
[2]	CHENG Yibang, LI Mingxuan, CHEN Bo, CAO Sheng, JIANG Gonghao, XU Jianzhong, LI Yan, WANG Jiguang. Diagnostic value of measuring the plasma renin and aldosterone by chemiluminescence immunoassay in the primary aldosteronism [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 474-480.
[3]	LI Zhoutong, ZHANG Wei, WANG Jiguang. Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 487-493.
[4]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 525-527.
[5]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 528-530.
[6]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 445-449.
[7]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 450-453.
[8]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 454-459.
[9]	HUANG Yongyan, YANG Lina, CAO Jiumei, WANG Wei. Cloud-based solution assisted blood pressure management in outpatient setting [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 319-324.
[10]	WANG Yajuan, GUO Qianhui, ZHANG Dongyan, CHENG Yibang, CHEN Ling, ZHU Dingliang, LI Yan. Prevalence of overweight and obesity and analysis of blood pressure related factors among children and adolescents in Xinzhuang community, Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 575-580.
[11]	HUANG Jianfeng, SHENG Changsheng, HUANG Qifang, CHENG Yibang, GUO Qianhui, ZHANG Dongyan, WANG Jiguang, LI Yan. Study on circadian blood pressure rhythmandrelated influencing factors in outpatients [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(03): 313-318.
[12]	WEI Jian, GAO Pingjin, HAN Weiqing. Effect of α7 nicotinic acetylcholine receptor activation on transforming growth factor β1-induced phenotypic transformation of adventitia fibroblasts studied in vitro [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 56-60.
[13]	GUO Tongshuai, CHU Chao, WANG Yang, REN Keyu, MU Jianjun. Effects of salt loading and potassium supplement on circadian blood pressure profile in salt-sensitive Chinese subjects [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 582-586.
[14]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 567-570.
[15]	CHEN Hui, GUO Qianhui, XU Jie, CHENG Yibang, ZHANG Dongyan, WANG Ying, HUANG Qifang, SHENG Changsheng, LI Yan. Prevalence and determinants of asymptomatic intracranial artery stenosis assessed by transcranial Doppler ultrosonography [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 592-595.